RALTEGRAVIR USE IN HIV-INFECTED PATIENTS

被引：0
|
作者：
Silvia Elena, Garcia-Ramos [1 ]
Garcia-Valdecasas Maria, Fernandez-Pacheco [1 ]
Perrin Rosario, Santolaya [1 ]
机构：
[1] Hosp Univ Principe Asturias, Serv Farm, Alcala De Henares, Madrid, Spain
来源：
ATENCION FARMACEUTICA | 2011年 / 13卷 / 04期
关键词：
INTEGRASE INHIBITOR RALTEGRAVIR; TREATMENT-EXPERIENCED PATIENTS; LONG-TERM EFFICACY; PHASE-II; SAFETY; THERAPY;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
  • [1] Therapeutic drug monitoring of raltegravir in HIV-infected patients
    Gouguet, C.
    Bregigeon, S.
    Pissier, C.
    Quaranta, S.
    Lacarelle, B.
    Solas, C.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 462 - 463
  • [2] Raltegravir in HIV-infected patients with high vascular risk
    Olalla, Julian
    del Arco, Alfonso
    de la Torre, Javier
    Salas, Daniel
    Luis Prada, Jose
    Garcia-Alegria, Javier
    [J]. MEDICINA CLINICA, 2012, 138 (03): : 107 - 109
  • [3] Raltegravir dosage adjustment in HIV-infected patients receiving etravirine
    Do, Vi T.
    Higginson, Robert T.
    Fulco, Patricia Pecora
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (21) : 2049 - 2054
  • [4] Efficacy, safety, and lack of interactions with the use of raltegravir in HIV-infected patients undergoing antineoplastic chemotherapy
    Banon, Sara
    Machuca, Isabel
    Araujo, Susana
    Moreno, Ana
    Perez-Elias, Maria J.
    Moreno, Santiago
    Luis Casado, Jose
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 69 - 69
  • [5] Pharmacokinetics of raltegravir in the semen of HIV-infected men
    Antoniou, Tony
    Loutfy, Mona R.
    Brunetta, Jason
    Smith, Graham
    Halpenny, Roberta
    la Porte, Charles
    [J]. ANTIVIRAL THERAPY, 2014, 19 (06) : 607 - 611
  • [6] Raltegravir - a new agent in HIV-infected treatment-naive patients?
    Dabrowska, Magdalena Monika
    Wiercinska-Drapalo, Alicja
    [J]. HIV & AIDS REVIEW, 2009, 8 (04): : 5 - 7
  • [7] Is Chewed Raltegravir an Option to Care for HIV-Infected Patients With Active Tuberculosis?
    Gervasoni, Cristina
    Riva, Agostino
    Impagnatiello, Caterina
    Galli, Massimo
    Cattaneo, Dario
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 (03) : 480 - 481
  • [8] Factors associated with virological response to raltegravir in experienced HIV-infected patients
    Marcelin, A. G.
    Delaugerre, C.
    Flandre, P.
    Descamps, D.
    Morand-Joubert, L.
    Amiel, C.
    Ferre, V.
    Izopet, J.
    Masquelier, B.
    Calvez, V.
    [J]. ANTIVIRAL THERAPY, 2011, 16 : A74 - A74
  • [9] Raltegravir in HIV-Infected Liver Transplant Recipients.
    Teicher, Elina
    Braun, Josephine
    Barau, Caroline
    Boulet, Thomas
    Eliette, Veronique
    Ralaimazava, Pascal
    Bonhomme, Laurence
    Abbara, Chadi
    Duclos-Vallee, Jean-Charles
    Taburet, Anne-Marie
    [J]. LIVER TRANSPLANTATION, 2011, 17 (06) : S150 - S151
  • [10] Pharmacokinetics of Raltegravir in HIV-Infected Patients on Rifampicin-Based Antitubercular Therapy
    Taburet, Anne-Marie
    Sauvageon, Helene
    Grinsztejn, Beatriz
    Assuied, Alex
    Veloso, Valdilea
    Pilotto, Jose Henrique
    De Castro, Nathalie
    Grondin, Carine
    Fagard, Catherine
    Molina, Jean-Michel
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 61 (08) : 1328 - 1335
12345